Tilray Brands, Inc. (FRA:2HQ0)
Germany · Delayed Price · Currency is EUR | Market Cap | 766.41M -20.4% |
| Revenue (ttm) | 722.11M +1.0% |
| Net Income | -1.82B |
| EPS | -17.98 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 18.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 450 |
| Average Volume | 1,815 |
| Open | 6.73 |
| Previous Close | 6.39 |
| Day's Range | 6.57 - 6.77 |
| 52-Week Range | 2.99 - 19.50 |
| Beta | n/a |
| RSI | 44.97 |
| Earnings Date | Apr 9, 2026 |
About Tilray Brands
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Financial Performance
In fiscal year 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
Don't Even Think About Buying Tilray Stock Until You Read This Warning
Tilray has been expanding beyond marijuana to include hemp products and alcoholic beverages. The company's strategy has led to top-line growth, but it has yet to generate sustainable profits.
Canadian Marijuana Stock Picks For Investors 2026
There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uph...
Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker?
Both companies have positioned themselves to capitalize on potential opportunities in the cannabis market. However, there is significant uncertainty ahead, due to regulatory issues (and other concerns...
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United State...
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals
NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical dist...
Is Tilray Stock Going to $0?
Tilray Brands has struggled to stay out of the red over the years, and that pattern may continue for the foreseeable future. The company's growth prospects are underwhelming.
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industr...
Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois
BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has annou...
Tilray's CC Pharma Recognized as a TOP 100 Innovator in Germany
DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceut...
Tilray Brands stock has crashed—but a bullish pattern is emerging
Tilray Brands stock price continued its strong downward trend, reaching its lowest level since December 9 last year. It has crashed by over 68% from its highest level in October last year.
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced
Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing C...
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture
ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Terrapin Beer Co. (Terrapin), a craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced a comprehensive brand refresh.
Tilray Has Already Done The Hard Part
Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, dr...
February 2026 Watchlist: Leading Canadian Cannabis Stocks
The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient in...
SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey's McGee, Thievery Corporation & Chromeo to Headline
ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX...
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
ATLANTA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc. (NASDAQ: TLRY and TSX...
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering...
Tilray Brands Just Posted Record Numbers for Q2. Is the Stock a Buy?
Tilray's fiscal second-quarter revenue of $217.5 million was a record high. Its cannabis business generated growth, but its beverage segment struggled.
This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy?
Tilray's latest financial results were fairly strong. The company could have a large market opportunity in the U.S. However, Tilray still faces significant challenges.
How to play cannabis stocks in 2026
President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure...
3 Canadian Marijuana Stocks For Investors In 2026
The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this ye...
International Cannabis Expansion Gives Tilray Positive 2026 Outlook
Tilray reported financial performance for Q2-2026 with international sales driving growth. Tilray remains undervalued after its reverse split and after the rally over rescheduling subsided. Tilray for...
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Why Tilray Brands Stock Is Rising in After-Hours Trading
Tilray reported Q2 2026 financial results after the bell today. The company reported improvements at the top and bottom of the income statement compared to the same period last year.